BofA Securities Reiterates Buy Rating on Medtronic, Inc. (MDT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Goldman Sachs Reiterates Sell Rating on Medtronic, Inc. (MDT)
July 11, 2025 12:26 PM EDTGoldman Sachs analyst David Roman reiterated a Sell rating and $78.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "On Thursday, July 10th, the Centers for Medicare and Medicaid Services (CMS) released a proposed Decision Memo to cover Renal Denervation (RDN) -- either radiofrequency (Medtronic) or ultrasound-based (Recor Medical, a subsidiary of... More
Raymond James Reiterates Market Perform Rating on Medtronic, Inc. (MDT)
July 11, 2025 8:22 AM EDTRaymond James analyst Jayson Bedford reiterated a Market Perform rating on Medtronic, Inc. (NYSE: MDT).
The analyst comments "CMS released its proposed National Coverage Determination (NCD) for Renal Denervation (RDN) last night (here). An NCD provides necessary scope around clinical eligibility for reimbursement purposes. The timeline was expected (on/before July 11). This document triggers another 30-day comment period, culminating with a final NCD expected to be published on/around October 8, 2025. Punchline: We believe the document reads well with no unexpected restrictions. CMSs inclusion threshold of 140 mmHg ambulatory blood pressure (which we believe equates... More
